Putting Consumers First: a New Era in Media at IBC2019
IBC2019 is excited to present brand new thought-provoking, stimulating and disruptive conference tracks and timely technological debates that are set to ignite the industry’s most influential media, entertainment and technology event. With the conference and exhibition dates now aligned, all attendees will find inspiration in IBC’s world-class conference, which this year is themed Consumers First: A New Era in Media.
IBC’s Content Steering Group (CSG), a collection of industry experts and thought leaders from diverse industry sectors brought together by IBC, are the driving force behind this year’s conference, setting the agenda for a compelling event program that addresses the biggest opportunities and challenges faced by the industry.
Keynote speakers will set the tone for the entire event, examining the current state of the industry and sharing their visions for the future. They include Cécile Frot-Coutaz, Head of EMEA, YouTube; Arnaud de Puyfontaine, Chairman, Vivendi; and Max Amordeluso, EU Lead Evangelist, Amazon Alexa.
The main conference is split into five new tracks, with a different daily focus on each stage of the end-to-end media content chain, with invaluable insight from over 300 expert speakers from around the world.
- Create & Produce: Creating Disruption offers insights into new technologies and concepts including interactivity and 8K production.
- Manage: Automating Media Supply Chains looks at AI and other new technologies that can create more successful media supply chains.
- Publish: Embracing the Platform Revolution presents new business models that are disrupting the industry.
- Consume: Engaging Consumer Experiences delves into consumer consumption habits and next-gen fan engagement.
- Monetise: Scaling Audiences and Revenues shines a light on brands as broadcasters and new models of advertising.
Each track will also feature Tech Talks, presenting cutting-edge technical papers and in-depth discussions on the technology enabling the media content chain.
The Global Gamechangers stage makes a welcome return to IBC, bringing the foremost innovators and business disruptors from across the media, entertainment and technology spectrum to share successes and stimulate debate. Gary Shapiro, President and CEO, Consumer Technology Association; Jane Turton, CEO, All3Media, and Lisa Opie, Managing Director, UK Production, BBC Studios are among the confirmed speakers who will discuss their opinions and experiences.
Esports, arguably the fastest growing sector in the industry, plays a major role at IBC2019 as this sector continues to experience unprecedented global growth. The IBC Esports Showcase, supported by ESL, Lagardère and EVS, will feature a first for IBC – a full esports tournament staged in the Auditorium, bringing the excitement and fan engagement generated by esports events, while demonstrating the size and scale of a typical event. The showcase will also present a series of esports focused scene-setters, panels, keynotes and interviews.
An exciting new collaboration between IBC and TM Forum will bring the Media-Telecom Catalyst projects to IBC. Three unique Catalyst projects will drive open innovation between the telecoms and media industries and include participation from Al Jazeera, Associated Press, BBC R&D, RTÉ and more to exploit 5G, AI, and data management to solve business and technology challenges and improve customer experience.
The Big Screen will deliver a stunning program of events and screenings that take full advantage of the very latest cinema projection and sound equipment. With sessions from the BBC Studios Natural History Unit ahead of Attenborough’s next big wildlife epic, Game of Thrones with an exclusive screening of The Long Night and the team behind Toy Story, in line with the release of Toy Story 4, the Big Screen is one of this, years must-attend features.
Award-wining news presenter and journalist, Kirsty Wark, will host this year’s invitation-only Leaders’ Forum, which once again will run alongside the Cyber Security Forum and Telco & Media Innovation Forum bringing together the industry’s most influential executives to discuss and debate the future of the industry.
The prestigious IBC Awards ceremony will take place on Sunday 15 September to celebrate the industry’s highest achievements. IBC is delighted to present two new awards this year: The Young Pioneer Award will recognise the outstanding commitment, ambition and achievement of young professionals in creative, technical, commercial or strategic roles; while the Social Impact Award will recognise a company initiative or campaign that is making a positive impact in the wider world.
Register for IBC2019 here: show.ibc.org
More details will follow in the coming weeks about additional speakers and features at IBC2019.
## ENDS ##
IBC is the world’s most influential media, entertainment and technology show, attracting 55,000+ attendees from more than 150 countries and combining a highly respected and peer-reviewed conference with an exhibition that showcases 1,700+ leading industry suppliers of state-of-the-art technology. In addition to the world-class exhibition and conference, IBC also encompasses the IBC Daily, IBCTV and IBC365.
IBC365 provides year-round insight and opinion into the hot topics and key trends from leading industry journalists, along with insightful whitepapers, peer reviewed technical papers, highly engaging webinars and an expansive video library.
Conference: 13 - 17 September 2019
Exhibition: 13 - 17 September 2019
For more information about IBC2019 visit: show.ibc.org
For further information, please contact:
Amy Swallow, Bubble Agency
T: +44 0203 137 1051
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ResMed Inc. Completes $500M Private Placement Debt Offering15.7.2019 20:05:00 CEST | Press release
ResMed Inc. (NYSE: RMD, ASX: RMD) announced today the successful pricing and closing of a private placement offering of $250,000,000 principal amount 3.24% senior notes due July 10, 2026, and $250,000,000 principal amount 3.45% senior notes due July 10, 2029. Net proceeds from the offering will be approximately $498 million, after deducting estimated fees and expenses related to the offering. The net proceeds will be used to pay down current borrowings on ResMed’s senior unsecured revolving credit facility. The notes are senior unsecured obligations of ResMed, and jointly and severally guaranteed by each Subsidiary Guarantor. “We are pleased to complete this U.S. private placement offering on attractive terms,” said Brett Sandercock, ResMed’s chief financial officer. “The transaction significantly lengthens our average debt maturity profile and provides improved visibility on our long-term funding costs.” This private placement offering is exempt from the registration requirements of t
SpeeDx Receives Clearance from Health Canada for ResistancePlus® MG Test15.7.2019 15:00:00 CEST | Press release
SpeeDx Pty. Ltd. today announced Resistance Plus® MG has been cleared by Health Canada and is now available for sale across all Canadian provinces (not currently available in the U.S.). The molecular diagnostic test detects the sexually transmitted infection (STI) Mycoplasma genitalium, also known as Mgen, along with genetic markers linked to antibiotic resistance. This is the first commercially available test in Canada combining identification and therapeutic guidance information to support Resistance Guided Therapy for management of Mgen. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190715005544/en/ (Photo: Business Wire) Current Canadian management guidelines for Mgen direct laboratories to forward positive samples to the National Microbiology Laboratory for resistance testing.1 Now Canadian laboratories can utilize Resistance Plus MG and bring this service inhouse to generate more timely results for doctors and their p
Mouser Electronics Now Stocking Broad Portfolio of Xilinx Products15.7.2019 14:55:00 CEST | Press release
Mouser Electronics, Inc. today announces a new global distribution agreement with Xilinx, Inc., the leader in adaptive and intelligent computing, to stock one of the industry’s broadest portfolios of Xilinx products, including digital downloads of development software and IP. Xilinx is the inventor of the FPGA, hardware programmable system-on-chips (SoCs) and the adaptive compute acceleration platform (ACAP), designed to deliver the most dynamic processor technology in the industry and enable the adaptable, intelligent and connected world of the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190715005546/en/ Mouser Electronics proudly announces a new global distribution agreement with Xilinx, Inc., the leader in adaptive and intelligent computing. Mouser will stock one of the industry’s broadest portfolios of Xilinx products. (Graphic: Business Wire) To learn more, visit www.mouser.com/xilinx. “Xilinx is an industry
Rimini Street Becomes Support Service Provider for Hyundai-Kia Motors’ Global Database Portfolio15.7.2019 13:00:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that it has been selected as the software support services provider to global auto manufacturer Hyundai-Kia Motors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190715005161/en/ Rimini Street announced that it has been selected as the software support services provider to global auto manufacturer Hyundai-Kia Motors. (Photo: Business Wire) By providing efficient, timely, and cost-effective database maintenance and support, Rimini Street plans to actively support Hyundai-Kia Motors in their endeavor to implement a business-driven IT roadmap. Cost Optimization and Desire for Quality Support To support response to paradigm shifts in the automobile industry and active technology innovation, Hyundai-Kia Motors se
Värde Partners Appoints Co-CEO15.7.2019 12:12:00 CEST | Press release
Värde Partners, a leading global alternative investment firm, today announced that Ilfryn Carstairs will join George Hicks, Co-Founder and Chief Executive Officer, as Co-CEO, effective January 1, 2020. George co-founded Värde Partners 25 years ago and intends to transition to an Executive Chair role in 2022. Ilfryn will retain his role as Global CIO. “Transition is a process and involves the entirety of the firm. The roles Ilfryn and I play are just part of that process whereby a new generation of leaders succeed the founders,” said George. “Ilfryn joined us 12 years into this journey and has grown as both an investor and a leader. His skills in both pursuits will enable Värde to continue delivering for our investors and will help to ensure that we maintain our strong culture long into the future.” Ilfryn is a Partner and Co-Chief Investment Officer overseeing the global investment strategy for Värde. He co-chairs the firm’s Investment Committee. Based in Singapore since 2017, he joine
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform15.7.2019 12:00:00 CEST | Press release
Boehringer Ingelheim today announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and advancing first-in-class therapeutic cancer vaccines derived from its technology platform KISIMA. AMAL’s lead vaccine ATP128 is currently developed for stage IV colorectal cancer and is slated to begin first-in-human trials later this month. Boehringer Ingelheim plans to develop new therapies by combining assets from its cancer immunology portfolio with AMAL’s proprietary KISIMA immunization platform. “Acquiring AMAL is part of Boehringer Ingelheim’s long-term strategy to enhance our existing position as an innovator of novel cancer therapies, including immuno-oncology treatments, which leverage cutting-edge scientific discoveries and their applications,” said Michel Pairet, member of Boehringer Ingelheim’s Board of Managing Directors with responsibility for the company’s Innovation Unit. “We want to pioneer new paradigms